Lazabemide hydrate
CAS: 103878-84-8
Ref. 3D-DEA87884
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire | |
250mg | To inquire |
Product Information
- 2-Pyridinecarboxamide, N-(2-aminoethyl)-5-chloro-
- 6-Chloropyridine-N-(3-hydroxypropyl)-2-carbonylamide
- Ccris 7301
- Lazabemide [USAN:INN]
- N-(2-Aminoethyl)-5-chloro-2-pyridinecarboxamide
- N-(2-Aminoethyl)-5-chloropicolinamide
- N-(2-aminoethyl)-5-chloropyridine-2-carboxamide
- Ro 19-6327/000
- Unii-420Hd787N9
Lazabemide hydrate is a drug that inhibits monoamine oxidase type A and B (MAO-A and MAO-B) enzymes, which are responsible for the degradation of dopamine, serotonin, and norepinephrine. It has been shown to be effective in treating bowel disease. Lazabemide hydrate can also be used to prevent or treat depression, Parkinson's disease, and other neurological disorders. Lazabemide hydrate is approved for use in the United States under the trade name Rasagiline Mesylate.
Chemical properties
Technical inquiry about: 3D-DEA87884 Lazabemide hydrate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.